We developed a new cationic lipid suitable for use as a DNA carrier in the presence of 10% sera. The novel compound (abbreviated as Arg-Chol) contains cholesterol and a dipeptide consisting of glycine and sterically protected arginine. The efficiency of reporter gene transfection using liposomes based on this new reagent was compared with that of liposomes made with other cationic derivatives of cholesterol. Lipoplexes formulated with the newly synthesized lipid mediate in vitro transfection of B16(F10) murine melanoma cells in the presence of 10% sera more efficiently than in other cell lines and compared with other cholesterol derivatives studied. Cancer Gene Therapy (2000) 7, 513-520
P rogress in nonviral gene therapy trials depends upon the availability of efficient agents for the transfer of therapeutic genes (reviewed in Ref. 1) . Nonviral carriers, based mostly on cationic lipids, are sensitive in vivo to blood serum-mediated degradation and are not resistant to the destructive action of the reticuloendothelial system.
Our aim was to synthesize a new cationic lipid that would enhance liposome stability in the presence of sera and allow more efficient transfection of targeted types of cells. We chose to couple cholesterol with arginine sterically protected with one N-tert-butoxycarbonyl group (BOC). It was believed that such a compound would be relatively easy to synthesize and that it should combine the advantages of its components. Cholesterol has long been known for its stabilizing effect on liposomal membranes exposed to blood. 2 Cholesterol has been used in syntheses of other cationic lipids, such as 3-␤-(N-[NЈ,NЈ-dimethylamino-ethane]carbamoyl)cholesterol (DC-Chol), 3 3-␤-(N 1 -[N, 4 N 8 -spermidine]carbamoyl)cholesterol/spermidine-cholesterol, 4 -6 cholesterol-(3-imidazol-1-yl propyl)carbamate, 7 and 3-␤-([NЈ,N-diguanidinoethylaminoethane]carbamoyl)cholesterol (BGTC). 8 In preparing liposomes, cholesterol has also been used as a neutral colipid. 9 -12 All of the above preparations have been used in several gene transfer studies in vitro or in vivo.
Arginine contains a strongly basic guanidine group that is capable of complexing DNA. Inclusion of sterically protected arginine in a cationic lipid has been described previously for a compound known as GS 2888. 13 Using the described approach, we obtained cholesteryl -BOC-arginine glycinate (abbreviated as Arg-Chol).
The efficiency of in vitro transfection mediated by liposomes containing this new lipid and dioleoyl-L-phosphatidylethanolamine (DOPE) was compared with that of liposomes containing other polycationic derivatives of cholesterol. We used three cell lines in transfection studies, either in the absence or presence of 10% fetal bovine sera (FBS): the B16(F10) murine melanoma cell line, the Renca murine renal carcinoma cell line, and the ECV304 human endothelial cell line.
MATERIALS AND METHODS

Syntheses of cationic lipids
Synthesis of glycyl ester of cholesterol was accomplished essentially according to the method described by Lapatsanis et al. 14 A total of 13 mmol of BOC-glycine (Sigma, St. Louis, Mo) in 20 mL of dichloromethane was reacted with 13 mmol of carbonyldiimidazole (Sigma) in 20 mL of dichloromethane for 30 minutes at 0°C. Next, 10 mmol of cholesterol (Sigma) in 20 mL of dichloromethane was added, and the mixture was stirred for 3 hours at 0°C. Subsequently, the mixture it was left at 20°C for 2 weeks. After solvent removal, the residue was dissolved in ethyl acetate; washed with water, ice-cold 1N H 2 SO 4 , water, saturated sodium bicarbonate, and water; dried over sodium sulfate, and evaporated to give the glycyl ester of cholesterol (74% yield, melting point 111-112°C/literature 111-115°C, ratio to front (R f ) ϭ 0.60 in chloroform/methanol (1:1 vol/vol) thin-layer chromatography (TLC) solvent system). The BOC was removed from the glycyl ester by treatment (30 minutes/ 20°C) with a mixture (per 1 mmol of ester) of 3 mL trifluoroacetic acid (TFA) and 3.5 mL dichloromethane. After evaporation under vacuum at 30°C, the oily residue was treated with absolute ether; the precipitate was collected by filtration, dried under vacuum over P 2 O 5 and KOH, and either recrystallized from ethyl acetate and methanol or chromatographed on a silica gel column (yield 66%).
To couple cholesterol with BOC-protected arginine, the unblocked glycyl ester of cholesterol (0.35 mmol as trifluoroacetate salt) in 10 mL of dichloromethane was reacted overnight at 20°C with 0.36 mmol of L-BOC-Arg(BOC) 2 In transfection studies, we used both crude and purified Arg-Chol preparations. The latter were obtained using either preparative TLC (benzene/ethyl acetate/methanol/triethylamine 10:5:5:1 vol/vol, R f ϭ 0.50) or reverse-phase highperformance liquid chromatography (HPLC) (Gynkotek 501 apparatus, C 18 TosoHaas 7.8 ϫ 300 mm column (TosoHaas, Stuttgart, Germany), mobile phase: 60% methanol/40% 50 mM ammonium acetate (pH ϭ 6.8), flow ϭ 1 mL per minute, temperature ϭ 40°C, diode array detector at 205-210 nm; retention time ϭ 16.30 minutes).
Two other cationic derivatives of cholesterol used in this study were also synthesized: BGTC 8 and DC-Chol. 3 The third cationic compound used, dimethyldioctadecyl ammonium bromide (DDAB), was obtained from Sigma.
Plasmid DNA preparation pGL3 reporter vector (Promega, Madison, Wis) carrying luciferase cDNA was used throughout the studies. Plasmid DNA was isolated from Escherichia coli spheroplasts according to the procedure described by Wicks et al. 15 
Liposome preparation
Cationic liposomes formed from DOPE and either Arg-Chol, BGTC, 8 DC-Chol, 3 or DDAB 16 were used as carriers of plasmid DNA. Liposomes were prepared from 10 mg/mL stock solutions of lipids in chloroform. Required aliquots were mixed, and solvent was removed with a rotary evaporator and more completely with a Speedvac (minimum 2 hours). Lipid films were then hydrated (at 1 mg/mL) for 2 hours and pulse-sonicated with cooling (probe sonifier, medium power setting; Branson, Danbury, Conn) until emulsions were clear.
Liposome preparations were maintained at 4°C and used within 2 weeks.
DNA electrophoretic mobility and degradation assays
Formation of complexes between plasmid DNA and cationic liposomes results in a change (retardation) in DNA electrophoretic mobility. We estimated the degree of complex formation between Arg-Chol:DOPE liposomes and pGL3 plasmid DNA by performing DNA electrophoretic mobility and degradation assays. In the former assay, 1-g aliquots of pGL3 DNA were first mixed with 2-, 5-, and 10-g aliquots of Arg-Chol:DOPE liposomes prepared at various ratios of component lipids (1:1, 2:1, 4:1, 5:1, or 7:1 (wt/wt)). After a 15-minute incubation at 20°C, the samples (25 L total volume) were mixed with 5 L of loading buffer (pH 7.8) containing 5 mM ethylenediaminetetraacetic acid (EDTA) and analyzed electrophoretically on 1% agarose gel in 1ϫ TBE buffer (pH 7.8) (for composition of loading buffer and TBE see Ref. 17) .
In serum-induced plasmid DNA degradation assays, ArgChol:DOPE-pGL3 lipoplexes that had been prepared as described above were further incubated with FBS (10% final) for 4 hours at 37°C. Samples were then mixed with EDTA (10 mM final) and sodium dodecyl sulfate (0.1% final) and heated to 55°C for 20 minutes 12 to dissociate DNA from cationic liposomes. Samples were then analyzed electrophoretically as described above.
In vitro transfer of plasmid DNA into eukaryotic cells Transfections were carried out in medium with a reduced amount of sera (Opti-MEM, Life Technologies). Briefly, 5 ϫ 10 4 cells were seeded onto 24-well plates and grown overnight in RPMI 1640 medium plus 10% FBS. A total of 1 g of plasmid DNA (pGL3) diluted to 50 L with Opti-MEM was added to an equal volume of Opti-MEM containing a specified amount of liposomes and incubated for 15 minutes at 20°C. A 900-L aliquot of Opti-MEM or RPMI 1640 plus 10% FBS was added to lipoplex preparations, which were subsequently transferred into the wells. Cells were exposed to lipoplexes for 4 hours at 37°C. Transfection medium was replaced with RPMI 1640 medium containing 10% FBS and antibiotics (100 U/mL penicillin and 100 g/mL streptomycin).
Reporter gene expression was quantitated at 48 hours posttransfection in cell lysates obtained from transfected cultures using the Luciferase Assay System (Promega). Luciferase activity was measured with a Lumat LB 9501/16 luminometer (Berthold, Bad Wildbad, Germany) in aliquots of B16(F10) lysates containing 0.1 g of total protein and in aliquots of Renca and ECV304 lysates containing 5 g of total protein.
RESULTS
Synthesis of Arg-Chol
The reaction scheme for the synthesis of Arg-Chol is shown in Figure 1 . First, a glycyl ester of cholesterol was obtained (Fig 1, steps I and II); this was followed by attaching tri-BOC-arginine to the synthesized ester (Fig 1, step III) via the standard carbodiimide method.
In this way, cholesteryl ester of tri-Arg-Chol was obtained. Two BOC groups were selectively removed (Fig  1, step IV) under acidic conditions (either TFA in dichloromethane (1:1 vol/vol) or 2.3 M hydrochloric acid in dioxane). One BOC group of arginine remains stably attached under these conditions. The final compound features cholesterol coupled via glycyl spacer to arginine, with one of its guanidine nitrogens protected by BOC.
Initial screening of Arg-Chol transfection ability in the absence of helper colipid showed that it had poor DNA delivery properties as a single lipid agent. Therefore, liposomes based on the new lipid were prepared with DOPE.
Preliminary study of the transfection activity of lipoplexes containing 1 g of pGL3 and 5 g of Arg-Chol: DOPE (4:1 (wt/wt)) liposomes prepared from either crude synthetic product or from preparative TLC-purified as well as HPLC-purified products showed that differences were not significant. 8 for crude, TLC-purified, and HPLC-purified products, respectively. This finding considerably simplifies the refining of the Arg-Chol synthesis product and makes the preparation of liposomes containing ArgChol more straightforward. Optimization of Arg-Chol:DOPE liposomes and Arg-Chol:DOPE-containing lipoplexes Before transfection experiments, we studied the degree of complex formation between liposomes containing Arg-Chol and pGL3 DNA. We also checked the stability of these lipoplexes after their exposure to blood sera (see Materials and Methods). Changes in the pattern of pGL3 DNA electrophoretic mobility were thus recorded (Fig 2) . Migration of 1 g of plasmid DNA is slowed down (retarded) by 5 and 10 g of liposomes formulated at the following Arg-Chol:DOPE (wt/wt) ratios: 2:1 (Fig 2A, lanes 6 and 7) , 4:1 (Fig 2A, lanes 9 and 10) , 5:1 (Fig 2A, lanes 12 and 13) , and 7:1 (Fig 2A, lanes 13 and  14) . The plasmid DNA in these complexes did not migrate from starting wells because its charge had been neutralized by cationic lipid. Migration of 1 g of plasmid DNA is also retarded by 2 g of Arg-Chol: DOPE liposomes formulated at 5:1 and 7:1 (wt/wt) ratios (Fig 2A, lanes 11 and 14) . In contrast, for 1:1 (wt/wt) Arg-Chol:DOPE, the amount of liposomes required to retard the migration of 1 g of DNA appears to be Ͼ5 g (Fig 2A, lane 3) . Data from the serum-induced DNA degradation assay demonstrate that the DNA in lipoplexes was partially sensitive to the deoxyribonuclease activity present in FBS during a 4-hour incubation at 37°C at all studied ratios of Arg-Chol to DOPE (Fig 2B) . However, at the Arg-Chol:DOPE weight ratios 1:1 ( Fig  2B, lanes 3-5) and 3:1 (Fig 2B, lanes 9 -11) , much more degraded plasmid DNA can be seen (low molecular weight bands) compared with the Arg-Chol:DOPE weight ratios 2:1 and 5:1 (Fig 2B, lanes 6 -8 and 12-14) , where more undegraded plasmid DNA (high molecular weight bands) is also present. The results of this assay indicate that liposomes 2:1 and 5:1 (wt/wt) form more stable complexes with DNA in vitro in the presence of 10% sera.
The transfection ability of Arg-Chol:DOPE-containing lipoplexes was examined in relation to the weight ratio of liposome constituents (Fig 3A) . For this purpose, luciferase gene expression was measured in B16(F10) melanoma cell lysates after gene transfer with lipoplexes formed at a 5:1 (wt/wt) ratio (5 g of Arg-Chol:DOPE liposomes of composition indicated on the x axis and 1 g of pGL3 DNA). In serum- -7) , Arg-Chol:DOPE (4:1 (wt/wt)) (lanes 8 -10), Arg-Chol: DOPE (5:1 (wt/wt)) (lanes 11-13), and Arg-Chol:DOPE (7:1 (wt/wt)) (lanes 14 -16). Uncomplexed pGL3 plasmid DNA (1 g) was loaded in lane 1. Electrophoresis conditions: 1% agarose gel, 75 V/1.5 hours. B: Stability of DNA-liposome complexes in the presence of 10% sera. pGL3 plasmid DNA aliquots (1 g) were incubated for 15 minutes at 20°C with 2, 5, and 10 g of Arg-Chol:DOPE (1:1 (wt/wt)) (lanes 3-5), Arg-Chol:DOPE (2:1 (wt/wt)) (lanes 6 -8), Arg-Chol:DOPE (3:1 (wt/wt)) (lanes 9 -11), and Arg-Chol:DOPE (5:1 (wt/wt)) (lanes [12] [13] [14] . Uncomplexed pGL3 DNA (1 g) was loaded in lane 1. FBS at a final concentration of 10% was added to lipoplexes and to uncomplexed pGL3 DNA (lane 2), and samples were for incubated 4 hours at 37°C. Samples were then mixed with EDTA at a final concentration of 10 mM and with sodium dodecyl sulfate at a final concentration of 0.5% and incubated for 20 minutes at 55°C. Electrophoresis conditions: same as in (A).
reduced cell culture medium (Opti-MEM), the transfection efficiency in B16(F10) cells exposed to lipoplexes containing Arg-Chol:DOPE (2:1 and 5:1 (wt/ wt)) was twice as high as that obtained with lipoplexes containing Arg-Chol:DOPE (3:1, 4:1, and 7:1 (wt/wt)) liposomes. The maximum levels of luciferase expression obtained with liposomes Arg-Chol:DOPE 2:1 and 5:1 (wt/wt) further indicate that these liposome for- Arg-Chol:DOPE-pGL3 lipoplexes are as follows: 1.9 (at a 2:1 liposome-DNA (wt/wt) ratio), 4.6 (at a 5:1 (wt/wt) ratio ); 9.2 (at a 10:1 (wt/wt) ratio), and 18.5 (at a 20:1 (wt/wt) ratio). Values of for 5:1 (wt/wt) Arg-Chol:DOPE-pGL3 lipoplexes are as follows: 2.3 (at a 2:1 liposome-DNA (wt/wt) ratio); 5.8 (at a 5:1 (wt/wt) ratio); 11.6 (at a 10:1 (wt/wt) ratio), and 23.2 (at a 20:1 (wt/wt) ratio). mulations are stable under in vitro cell culture conditions.
We sought optimal conditions for in vitro transfection, mediated by Arg-Chol:DOPE-pGL3 lipoplexes exposed to 10% sera, in three cell lines: murine melanoma B16(F10), murine renal carcinoma Renca, and human endothelial ECV304 (Fig 3B) . In a typical experiment, 1-g aliquots of pGL3 DNA were complexed with increasing amounts of Arg-Chol:DOPE (2:1 and 5:1 (wt/wt)) liposomes (see Materials and Methods). Transfection assays in all three cell lines demonstrated that there is little difference in the level of reporter gene activity between 2:1 and 5:1 (wt/wt) Arg-Chol:DOPE liposomes, which correlates with small differences between respective values ( is the ratio of positive to negative charge in the lipoplex). However, an increase in the value from 1.9 to 5.8 (see caption of Fig 3B) corresponds to a 2-to 6-fold increase in luciferase expression, depending upon cell type. At higher values (up to 23.2), luciferase expression remains high; this high expression reflects the stability of lipoplexes with a high positive charge and underscores their ability to efficiently protect plasmid DNA from enzymatic attack in biological environment. The highest absolute luciferase activity was found in B16(F10) melanoma cell lysates, whereas ECV304 cells yielded the lowest transfection with ArgChol:DOPE liposomes. For 1 g of transfected pGL3 DNA, the optimal amount of Arg-Chol:DOPE liposomes giving maximal luciferase expression was 10 g of Arg-Chol:DOPE (2:1 (wt/wt)) for B16(F10) as well as Renca cells and 5 g of Arg-Chol:DOPE (5:1 (wt/wt)) for ECV304 cells, respectively. We noted that the lipoplexes with optimized composition showed higher gene expression in combination with lower cytotoxicity (data not shown).
Transfection of different cell lines using various optimized lipoplexes
The effectiveness of reporter gene transfer into the three cell lines studied (B16(F10), Renca, and ECV304) was compared for lipoplexes containing the newly synthesized cationic lipid Arg-Chol and for lipoplexes made with two other cationic cholesterol derivatives, BGTC and DC-Chol. Lipoplexes prepared with DDAB, which is a non-cholesterol-containing cationic lipid allowing high expression in all three cell lines, were also studied. Figure 4 juxtaposes data collected in several experiments in which the transfection ability of optimized Arg-Chol-containing liposomes as well as that of optimized "reference" liposomes was tested in three chosen cell lines. The optimum composition of all liposomepGL3 DNA complexes studied had been established for Opti-MEM and RPMI 1640 plus 10% FBS transfection media (data not shown). The composition of lipoplexes is indicated in the legend to Figure 4 (i.e., the amount of liposomes per 1 g of pGL3 DNA). In B16(F10) murine melanoma cells, the level of reporter gene expression in the presence of 10% sera was 2.5 times higher for Arg-Chol: DOPE liposomes than for DDAB:DOPE and DC-Chol: DOPE liposomes (Fig 4A) . A comparable level of transfection was obtained with the lipoplexes Arg-Chol:DOPE and DDAB:DOPE in Renca cells (Fig 4B) . The highest transfection efficiencies for Renca and ECV304 cells in 10% serum-containing medium were obtained for DC-Chol:DOPE liposomes (Fig 4, B and C) .
DISCUSSION
A new cationic cholesterol derivative was synthesized. It enlarges the panel of amphiphilic compounds with possible application in gene transfer. In formulating this reagent, we exploited the same DNA-condensing moiety (mono-BOC-protected arginine) used in GS 2888 (see Ref. 13) ; however, we coupled it with cholesterol instead of myristyl residues. The new lipid features a hydrophilic "head group" with three basic centers located in the arginine moiety and a hydrophobic cholesterol "anchor." Such a polycationic amphiphile should not only have good DNA-condensing properties but should also confer increased resistance to degradation to liposomes in a serum-containing environment. 18, 19 The synthesized crude Arg-Chol as well as its TLCand HPLC-purified preparations appear to have a similar capability to cause the transfer of reporter plasmid DNA (see Materials and Methods); all three were found suitable for transfection studies.
The optimum composition of liposomes containing this new cationic lipid and a neutral cohelper lipid, DOPE, was investigated in assays making use of the change in plasmid DNA electrophoretic mobility after the formation of DNA-liposome complexes as well as after serum-induced degradation of DNA in these complexes (Fig 2) . The assays show that DNA in lipoplexes at Arg-Chol:DOPE ratios of 2:1 and 5:1 (wt/wt) ( ϭ 4.6 and 5.8, respectively) most effectively resist the action of serum nucleases. This finding suggests effective DNA condensation by such liposome formulations. These Optimized lipoplexes were used to transfect cells seeded on 24-well plates. Lipoplex formation was achieved in Opti-MEM; transfections (4 hours) were performed in Opti-MEM or RPMI 1640 plus 10% FBS. A: A total of 2 g BGTC:DOPE (1.44:1 (wt/wt)) to 1 g of pGL3, 5 g of DC-Chol:DOPE (1:1 (wt/wt)) to 1 g of pGL3, 5 g of Arg-Chol:DOPE (2:1 (wt/wt)) to 1 g of pGL3, and 5 g of DDAB:DOPE (0.6:1 (wt/wt)) to 1 g of pGL3. B: A total of 4 g of BGTC:DOPE (1.44:1 (wt/wt)) to 1 g of pGL3, 10 g of DC-Chol:DOPE (1:1 (wt/wt)) to 1 g of pGL3, 10 g of Arg-Chol:DOPE (2:1 (wt/wt)) to 1 g of pGL3, and 2 g of DDAB:DOPE (0.6:1 (wt/wt)) to 1 g of pGL3. C: A total of 5 g of BGTC:DOPE (1.44:1 (wt/wt)) to 1 g of pGL3, 5 g of DC-Chol:DOPE (1:1 (wt/wt) to 1 g of pGL3, 5 g of Arg-Chol:DOPE (5:1 (wt/wt)) to 1 g of pGL3, and 5 g of DDAB:DOPE (0.6:1 wt/wt)) to 1 g of pGL3. Luciferase activity was assayed at 48 hours posttransfection. Each bar represents the mean Ϯ SD of triplicate determinations in separate experiments. results were confirmed by transfection studies (Fig 3A) . Two transfection maxima seen in Figure 3A correspond to molar ratios (2.1:1 and 5.4:1) of Arg-Chol to DOPE (equivalent to Arg-Chol:DOPE 2:1 and 5:1 (wt/wt)) at which condensation of small DNA amounts was found to have been the most effective. These observations are similar to those of Felgner et al 20 and Lee et al. 21 A high to moderately high expression level of reporter gene in the presence of 10% sera was found in the three cell lines investigated when cultures were exposed to Arg-Chol:DOPE-containing lipoplexes bearing a high positive charge ( values from 4.6 to 23.2, Fig 3B) . This emphasizes our finding that under physiological conditions, the newly synthesized lipid is capable of efficiently protecting plasmid DNA.
Our data show that the new compound, Arg-Chol, is suitable for efficiently transfecting the B16(F10) murine melanoma epithelial cell line. Arg-Chol:DOPE liposomes promoted the highest absolute transfection of these cells in 10% serum-containing medium compared with other cationic liposomes tested (Fig 4A) . Arg-Chol does not appear to be suitable for transfecting murine renal carcinoma cells or human endothelial cells. In the former cell line, maximum transfection efficiency in the presence of 10% sera was attained with DC-Chol:DOPE liposomes followed by DDAB:DOPE ( Fig 4B) ; in the latter cell line, DC-Chol:DOPE and BGTC:DOPE liposomes appear to work best under the transfection conditions used (Fig 4C; also see Ref. 22 ). Thus, Arg-Chol: DOPE liposomes yielded a high expression of reporter gene in epithelial melanoma cells as opposed to less prominent expression in endothelium-derived Renca and ECV304 cells.
In summary, the synthesized novel cationic lipid ArgChol is suitable for transfecting certain types of cells in the presence of 10% sera.
